Documentation Centre

 

 

  of 1483 Next page

Go to page: of

Screenshot Date Categories Title Author Format
HDL-cholesterol, genetics, and coronary artery disease: the myth of the 'good cholesterol'? Eur Heart J. 2018;39:2179-2182. October 17, 2018 HDL-cholesterol, genetics, and coronary artery disease: the myth of the 'good cholesterol'? Eur Heart J. 2018;39:2179-2182. Landmesser U, Hazen S Key Publications
Comparison of low-density lipoprotein cholesterol assessment by Martin/Hopkins estimation, Friedewald estimation, and preparative ultracentrifugation: Insights from the FOURIER trial. JAMA Cardiol. 2018 doi: 10 October 16, 2018 Comparison of low-density lipoprotein cholesterol assessment by Martin/Hopkins estimation, Friedewald estimation, and preparative ultracentrifugation: Insights from the FOURIER trial. JAMA Cardiol. 2018 doi: 10 Martin SS, Giugliano RP, Murphy SA, Wasserman SM, Stein EA, Ceška R, López-Miranda J, Georgiev B, Lorenzatti AJ, Tikkanen MJ, Sever PS, Keech AC, Pedersen TR, Sabatine MS Key Publications
Rare SCARB1 mutations associate with high-density lipoprotein cholesterol but not with coronary artery disease. Eur Heart J. 2018;39:2172-2178 October 16, 2018 Rare SCARB1 mutations associate with high-density lipoprotein cholesterol but not with coronary artery disease. Eur Heart J. 2018;39:2172-2178 Helgadottir A, Sulem P, Thorgeirsson G, Gretarsdottir S, Thorleifsson G, Jensson BÖ, Arnadottir GA, Olafsson I, Eyjolfsson GI, Sigurdardottir O, Thorsteinsdottir U, Gudbjartsson DF, Holm H, Stefansson K Key Publications
Measuring low-density lipoprotein cholesterol: When is more accurate better? JAMA Cardiol. 2018 doi: 10 October 16, 2018 Measuring low-density lipoprotein cholesterol: When is more accurate better? JAMA Cardiol. 2018 doi: 10 Stone NJ Key Publications
Walnut consumption alters the gastrointestinal microbiota, microbially derived secondary bile acids, and health markers in healthy adults: A randomized controlled trial. J Nutr. 2018;148:861-867 October 15, 2018 Walnut consumption alters the gastrointestinal microbiota, microbially derived secondary bile acids, and health markers in healthy adults: A randomized controlled trial. J Nutr. 2018;148:861-867 Holscher HD, Guetterman HM, Swanson KS, An R, Matthan NR, Lichtenstein AH, Novotny JA, Baer DJ Key Publications
Non-LDL dyslipidemia is prevalent in the young and determined by lifestyle factors and age: The LifeLines cohort. Atherosclerosis. 2018;274:191-198 October 11, 2018 Non-LDL dyslipidemia is prevalent in the young and determined by lifestyle factors and age: The LifeLines cohort. Atherosclerosis. 2018;274:191-198 de Vries JK, Balder JW, Pena MJ, Denig P, Smit AJ Key Publications
HDL cholesterol efflux capacity and cholesteryl ester transfer are associated with body mass, but are not changed by diet-induced weight loss: A randomized trial in abdominally obese men. Atherosclerosis. 2018;274:23-28 October 10, 2018 HDL cholesterol efflux capacity and cholesteryl ester transfer are associated with body mass, but are not changed by diet-induced weight loss: A randomized trial in abdominally obese men. Atherosclerosis. 2018;274:23-28 Talbot CPJ, Plat J, Joris PJ, Konings M, Kusters YHAM, Schalkwijk CG, Ritsch A, Mensink RP Key Publications
Is Lp(a) ready for prime time use in the clinic? A pros-and-cons debate. Atherosclerosis. 2018;274:16-22 October 10, 2018 Is Lp(a) ready for prime time use in the clinic? A pros-and-cons debate. Atherosclerosis. 2018;274:16-22 Kostner KM, Kostner GM, Wierzbicki AS Key Publications
Comparison of lipid accumulation product index with body mass index and waist circumference as a predictor of metabolic syndrome in Indian population. Metab Syndr Relat Disord. 2018;16:240-245 October 02, 2018 Comparison of lipid accumulation product index with body mass index and waist circumference as a predictor of metabolic syndrome in Indian population. Metab Syndr Relat Disord. 2018;16:240-245 Ray L, Ravichandran K, Nanda SK Key Publications
Predicting the effect of fenofibrate on cardiovascular risk for individual patients with type 2 diabetes. Diabetes Care. 2018;41:1244-1250 September 21, 2018 Predicting the effect of fenofibrate on cardiovascular risk for individual patients with type 2 diabetes. Diabetes Care. 2018;41:1244-1250 Koopal C, Visseren FLJ, Westerink J, van der Graaf Y, Ginsberg HN, Keech AC Key Publications

  of 1483 Next page

Go to page: of